Skip to content

Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients

Validation of a Portable Monitoring System for the Diagnosis of Obstructive Sleep Apnea Syndrome in Patients With Level II and III Obesity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01455077
Enrollment
40
Registered
2011-10-19
Start date
2011-01-31
Completion date
2012-01-31
Last updated
2011-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obstructive Sleep Apnea Syndrome

Keywords

obesity, sleep apnea, portable monitoring

Brief summary

Introduction The portable monitoring system (PMS) recording of cardiopulmonary parameters (level III of ASDA) has been validated in subjects with high probability of Obstructive Sleep Apnea (OSA) without comorbidities. However, there is not any study evaluating this system when OSA is associated with morbid obesity, so the validation of PMS will be very useful in order to properly work-up this highly risk population. Objective: To evaluate the accuracy of level III type of PMS - Stardust™ (STD), on patients with level II and III of obesity and high clinical suspicion of OSA. Methods:Participants with BMI \> 35 kg/m2 and with suspicion of OSA will consecutively be selected from an Outpatients Sleep Clinic of UNIFESP. They will be randomized for the following order of recordings: 1\) STD at home for 1 night 2) STD in the sleep lab simultaneous to PSG. AHI will be taken for subsequent analysis:a) AHI PSG b) AHI STD -lab and c) AHI STD- home.

Interventions

None listed

Sponsors

Federal University of São Paulo
CollaboratorOTHER
Associacao Fundo de Incentivo a Psicofarmcologia
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \> 35 * Complaints of snoring, sleep apnea, daytime sleepiness

Exclusion criteria

* use of home oxygen * other sleep diseases * inability to perform PSG

Countries

Brazil

Contacts

Primary ContactLia R Bittencourt, MD, PhD
lia@psicobio.epm.br55 11 21490155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026